I first came in touch with egg freezing about ten years ago, when Facebook and Google made headlines for offering to cover the cost for their employees. At the time, I was living in Austria, where the news was met with criticism. The general sentiment? Instead of encouraging women to delay motherhood, shouldn’t we be fixing childcare and creating conditions that make it easier for people to have children while building their careers?
A Süddeutsche Zeitung article from that time summed it up well: A freezer alone does not equal equality. Critics questioned whether this benefit truly empowered women - or subtly pressured them to put their family plans on hold in service of their employers’ goals. Others pointed out the underlying issue: the incompatibility of current societal structures with biological realities. Social egg freezing, they argued, offered a technological workaround, not a solution to systemic problems.
Fast forward to today - and the conversation has evolved.
WIN’s recent Delay of Motherhood report, 79% of women who became mothers after age 35 said they would make the same choice again, despite fertility challenges. Lifestyle, finances, and career goals remain key reasons for delaying motherhood, and most women feel empowered by that choice - not pressured. What has changed? A growing awareness of the need for support: 81% of women now consider employer-sponsored fertility benefits a non-negotiable.
The egg freezing conversation has grown from one about control and corporate incentives to one about access, equity, and empowerment. And with this shift, we’re also seeing new business models emerge - from benefit platforms and insurance-backed care to infrastructure players rethinking what fertility preservation looks like behind the scenes.
Let’s take a closer look at how the business of egg freezing is evolving.
Business Models in Egg Freezing
As interest in fertility preservation has grown, so has the range of business models designed to support it. What began as a niche, out-of-pocket procedure is now a dynamic ecosystem of companies tackling cost, access, education, and infrastructure from different angles.
Here’s how the sector is shaping up:
1. Direct-to-Consumer (DTC)
The DTC model is where much of the early innovation in egg freezing happened. Companies like Extend Fertility and Spring Fertility built branded, patient-first experiences that simplified what was historically a complex and opaque process. These clinics bundle services like testing, retrieval, and storage, often with financing and education built in - all targeting individuals rather than institutions.
Another standout in the DTC space, that recently made headlines for its $7M+ Series A is Cofertility, which offers a unique “Split” program allowing women to freeze their eggs for free in exchange for donating half. This approach lowers cost barriers and addresses gaps in the donor market - particularly around diversity - by creating a mutually beneficial alternative to traditional donation.
2. B2B: Fertility as a Workplace Benefit
Fertility benefit providers like Carrot Fertility, or Progyny are building infrastructure to make egg freezing and other services accessible through employers. These companies work directly with HR teams to design, implement, and manage fertility benefits as part of broader employee health packages.
Their role includes everything from patient navigation and clinic vetting to claims processing and outcomes tracking. In doing so, they help employers attract and retain talent, while giving individuals access to services that might otherwise be out of reach. As mentioned earlier: According to WIN’s Delay of Motherhood report, 81% of women now view fertility benefits as essential - not optional.
3. Hybrid Models: From DTC to Enterprise
Some companies begin by serving consumers directly, then expand into partnerships with employers, health plans, or platforms. This hybrid strategy allows early validation and brand-building through DTC channels, while positioning for scale through institutional sales.
Kindbody is one of the clearest examples of this model. The company started as a DTC clinic and brand but now offers on-site and virtual fertility care through corporate partnerships. Its growth illustrates how startups can use consumer trust as a springboard into the benefits space - and how many see B2B as the long-term engine of scale.
4. Financing & Insurance: Reducing Risk and Expanding Access
To this day affordability remains one of the biggest barriers to fertility care - and a growing set of companies are focused on solving it. While many clinics offer basic payment plans, newer players are going further, embedding financing and risk management into their core model.
Future Family is an example here. Their newly launched Orange Shield program functions like IVF insurance: Patients pay an upfront fee and receive a refund if treatment doesn’t result in a live birth after two cycles. It’s a novel approach to fertility protection that aligns incentives, reduces emotional stress, and can simplify decision-making for families facing significant uncertainty.
5. Infrastructure & Enablement Layers
Finally, there’s a layer of companies working behind the scenes to improve clinical outcomes and streamline operations. These infrastructure providers are building the tools that power fertility clinics, benefit platforms, and labs.
TMRW Life Sciences, for example, offers an automated cryostorage system that digitizes and secures the storage of frozen eggs and embryos — reducing the risk of error and improving traceability.
Beyond the Business Model: A Growing Cultural Conversation
Alongside the innovation in business models, the cultural conversation around egg freezing is also shifting - and becoming more nuanced.
In sports, for example, egg freezing is increasingly discussed as a way to extend reproductive timelines for elite athletes, whose peak performance years often overlap with peak fertility. Cofertility’s recent Level the Playing Field campaign - which brought together Olympians and investors to talk openly about fertility and athletic careers - is a sign of this growing intersection between reproductive health and performance culture.
In cancer care, egg freezing is gaining more visibility as a critical component of oncofertility. Fertility preservation is becoming part of the care plan for patients undergoing treatments that could impact their reproductive health - and startups, clinics, and non-profits alike are working to ensure timely access and coverage.
But not all attention is positive. Egg freezing has also been pulled into the wider vortex of fertility anxiety, especially on social media. Between influencer testimonials, clinic marketing, and algorithm-driven content, the message that time is running out is everywhere. For some, that messaging provides agency and information. For others, it creates pressure - or worse, a false sense of security about what freezing eggs can guarantee.
Egg freezing isn’t just a medical decision anymore - it’s a cultural touchpoint. One that reflects how we think about time, career, relationships, and the expectations we place on women’s bodies.
The technology is powerful. But like any tool, how it’s used - and who it truly empowers - depends on the systems around it.
